Back to Trials
NCT01745237Recruiting

Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis

Duke University

Start Date

9/1/2002

Completion Date

6/1/2032

Summary

The primary objective of this study was to determine the ability of cardiac magnetic resonance (CMR) to identify cardiac involvement in patients with sarcoidosis. Patients were to undergo CMR in addition to routine clinical evaluation.

Detailed Description

In patients with sarcoidosis, cardiac death is a leading cause of mortality which may represent unrecognized cardiac involvement. Cardiovascular magnetic resonance (CMR) can detect cardiac involvement including minute amounts of myocardial damage. Therefore, the objective of this study was to determine the usefulness of CMR and compare it with standard clinical evaluation for cardiac involvement. Patients with documented extracardiac sarcoidosis or clinically suspected cardiac sarcoidosis will be enrolled.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Biopsy proven sarcoidosis * Suspected cardiac sarcoidosis Exclusion Criteria: * Contraindication to MRI

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Sarcoidosis

Locations

Duke University Medical Center

Durham, North Carolina 27707

United States